Screening for prostatic cancer.

Tumor Markers For Prostatic Cancer (Is there a screening test for Prostatic Cancer?)

Prostatic-Specific Antigen (PSA) is a low-molecular weight glycoprotein, that is uniquely associated with prostatic tissue. It has considerable diagnostic specificity for prostatic disease. Concentrations of PSA in serum correlate well with the stage of disease, and response to treatment in patients with prostatic cancer. It is, therefore, a good tumor marker for prostatic cancer. However, it h...

[Cost-effectiveness analysis of prostatic cancer screening].

BACKGROUND To evaluate how much mass screening for prostatic cancer (PC) would benefit the nation economically, cost-effectiveness of PC screening was analyzed. METHODS The cost per life-year saved (cost-effectiveness ratio; CER) was compared between PC screening and other 5 already established cancer screenings in Japan by an analytical simulation model to estimate cost and effectiveness of ...

Cost-effectiveness analysis of strategies for screening prostatic cancer.

Screening for cervical cancer and precancerous lesions in Tabriz

 Abstract Background: Cervical cancer is the most common female genital tract malignancy and is the major cause of death from gynecologic cancer worldwide. The majority of cervical cancers develop through a series of gradual, precancerous lesions. Screening asymptomatic women with regular Pap smears allows diagnosis of the readily treatable preinvasive phase. We performed this study to determin...

Breast Cancer and Screening

سرطان پستان یکی از شایع ترین بیماریهای بدخیم و اولین علت مرگ و میر زنان بوده و تقریبا یک سوم تمام سرطانهای زنان را تشکیل می دهد.